Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP584390.RAeK9o2AbexolsqL7rk3XIYFIC4ubK8cnPI5MN8RaDe2M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP584390.RAeK9o2AbexolsqL7rk3XIYFIC4ubK8cnPI5MN8RaDe2M130_assertion type Assertion NP584390.RAeK9o2AbexolsqL7rk3XIYFIC4ubK8cnPI5MN8RaDe2M130_head.
- NP584390.RAeK9o2AbexolsqL7rk3XIYFIC4ubK8cnPI5MN8RaDe2M130_assertion description "[Thus, MYOD1 p.Leu122Arg defines a subset of rhabdomyosarcomas eligible for high-risk protocols and the development of targeted therapeutics.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP584390.RAeK9o2AbexolsqL7rk3XIYFIC4ubK8cnPI5MN8RaDe2M130_provenance.
- NP584390.RAeK9o2AbexolsqL7rk3XIYFIC4ubK8cnPI5MN8RaDe2M130_assertion evidence source_evidence_literature NP584390.RAeK9o2AbexolsqL7rk3XIYFIC4ubK8cnPI5MN8RaDe2M130_provenance.
- NP584390.RAeK9o2AbexolsqL7rk3XIYFIC4ubK8cnPI5MN8RaDe2M130_assertion SIO_000772 24793135 NP584390.RAeK9o2AbexolsqL7rk3XIYFIC4ubK8cnPI5MN8RaDe2M130_provenance.
- NP584390.RAeK9o2AbexolsqL7rk3XIYFIC4ubK8cnPI5MN8RaDe2M130_assertion wasDerivedFrom befree-20150227 NP584390.RAeK9o2AbexolsqL7rk3XIYFIC4ubK8cnPI5MN8RaDe2M130_provenance.
- NP584390.RAeK9o2AbexolsqL7rk3XIYFIC4ubK8cnPI5MN8RaDe2M130_assertion wasGeneratedBy ECO_0000203 NP584390.RAeK9o2AbexolsqL7rk3XIYFIC4ubK8cnPI5MN8RaDe2M130_provenance.